{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:32:09Z","timestamp":1768253529215,"version":"3.49.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Because of the continued demand in kidney transplantation, organs from donors with risk criteria for blood-borne viruses, high Kidney Donor Profile Index (KDPI) kidneys, and hepatitis C virus (HCV)\u2013positive kidneys are being considered. There continues to be reluctance on the part of the providers and the candidates to accept HCV-positive kidneys.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We conducted a retrospective analysis of the Organ Procurement and Transplantation Network database of all adult (\u226518 y old) recipients undergoing kidney transplant from May 10, 2013, to June 30, 2021. We compared patient and graft survival in candidates who received HCV-positive kidneys versus non\u2013hepatitis C (Hep C) high KDPI kidneys by estimated posttransplant survival (EPTS) groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>HCV-viremic kidneys were transplanted in 5.6% of patients in the EPTS &gt;61% group compared with 5.1% of patients in the 21%\u201360% EPTS group and 1.9% of 0%\u201320% EPTS group (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Of all transplants performed in the EPTS 61%\u2013100% group, 11.9% were KDPI &gt;85% compared with 5.2% in the EPTS 21%\u201360%, and 0.5% in the EPTS 0%\u201320%. Patient survival was significantly longer at 1, 3, and 5 y in the EPTS &gt;61% group who received Hep C\u2013viremic or \u2013nonviremic allografts compared with non\u2013Hep C kidneys with KDPI &gt;85%. When it comes to listing, only 25% of candidates in the EPTS &gt;61% group were listed for Hep C nucleic acid testing\u2013positive kidneys in 2021.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Our findings could be used for counseling candidates on the types of kidneys they should consider for transplantation. Also, listing practices for viremic Hep C kidneys need continued re-evaluation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004179","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T19:00:18Z","timestamp":1654714818000},"page":"2217-2223","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Survival Benefit in Older Patients Transplanted With Viremic Hepatitis C Positive Kidneys When Compared With High KDPI Kidneys"],"prefix":"10.1097","volume":"106","author":[{"given":"Lena","family":"Sibulesky","sequence":"first","affiliation":[{"name":"Division of Transplant Surgery, Department of Surgery, University of Washington, Seattle, WA."},{"name":"Clinical and Bio-Analytics Transplant Laboratory (CBATL), University of Washington Medical Center, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolae","family":"Leca","sequence":"additional","affiliation":[{"name":"Clinical and Bio-Analytics Transplant Laboratory (CBATL), University of Washington Medical Center, Seattle, WA."},{"name":"Division of Nephrology, Department of Medicine, University of Washington Medical Center, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajit P.","family":"Limaye","sequence":"additional","affiliation":[{"name":"Clinical and Bio-Analytics Transplant Laboratory (CBATL), University of Washington Medical Center, Seattle, WA."},{"name":"Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington Medical Center, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bakthavatsalam","family":"Ramasamy","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Department of Surgery, University of Washington, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Division of Transplant Surgery, Department of Surgery, University of Washington, Seattle, WA."},{"name":"Clinical and Bio-Analytics Transplant Laboratory (CBATL), University of Washington Medical Center, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1111\/ajt.13971","article-title":"Improving organ utilization to help overcome the tragedies of the opioid epidemic.","volume":"16","author":"Goldberg","year":"2016","journal-title":"Am J Transplant"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/ajt.14577","article-title":"Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.","volume":"18","author":"Bowring","year":"2018","journal-title":"Am J Transplant"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MOT.0000000000000603","article-title":"Marginal kidney transplantation: the road less traveled.","volume":"24","author":"Sharma","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/ajt.14978","article-title":"Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor-recipient combination.","volume":"19","author":"Bae","year":"2019","journal-title":"Am J Transplant"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/ajt.14381","article-title":"The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation.","volume":"17","author":"Levitsky","year":"2017","journal-title":"Am J Transplant"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ekir.2020.02.001","article-title":"Kidney transplantation from a hepatitis C virus-infected donor into an uninfected recipient: ready for prime time?","volume":"5","author":"Pagan","year":"2020","journal-title":"Kidney Int Rep"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/ajt.15152","article-title":"Transplantation of HCV-infected organs into uninfected recipients: advance with caution.","volume":"19","author":"Wadei","year":"2019","journal-title":"Am J Transplant"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/ajt.12835","article-title":"Hepatitis C virus infection and kidney transplantation in 2014: what\u2019s new?","volume":"14","author":"Baid-Agrawal","year":"2014","journal-title":"Am J Transplant"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1111\/ajt.14701","article-title":"Are we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider.","volume":"18","author":"Sibulesky","year":"2018","journal-title":"Am J Transplant"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/TP.0000000000002949","article-title":"Impact of donor hepatitis C virus on kidney transplant outcomes for hepatitis C-positive recipients in the direct-acting antiviral era: time to revise the kidney donor risk index?","volume":"104","author":"Cannon","year":"2020","journal-title":"Transplantation"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2215\/CJN.10960720","article-title":"Trends in discard of kidneys from hepatitis C viremic donors in the United States.","volume":"16","author":"Chang","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients.","volume":"376","author":"Goldberg","year":"2017","journal-title":"N Engl J Med"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients: an open-label nonrandomized trial.","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1111\/ajt.15530","article-title":"Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: single center experience.","volume":"19","author":"Molnar","year":"2019","journal-title":"Am J Transplant"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"e13540","DOI":"10.1111\/tid.13540","article-title":"Hepatitis C-positive donor to negative recipient kidney transplantation: a real-world experience.","volume":"23","author":"Jandovitz","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/ajt.15583","article-title":"Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: a unique complication in the DAA era.","volume":"20","author":"Kapila","year":"2020","journal-title":"Am J Transplant"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000502049","article-title":"Provider attitudes toward the use of hepatitis C virus-positive organs in kidney transplantation.","volume":"50","author":"Couri","year":"2019","journal-title":"Am J Nephrol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:02:52Z","timestamp":1749063772000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004179","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,27]]}}}